HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
5 hedge funds and large institutions have $2.49M invested in Hepion Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$446K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$187K |
Top Sellers
| 1 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$126K |
| 2 |
JPMorgan Chase & Co
New York
|
-$105K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$78K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$57K |
| 5 |
Morgan Stanley
New York
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BWA
26
BDO Wealth Advisors
Jacksonville,
Florida
| $1K | -$2K | – | – |
|
27
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$8K | – | – |
|
|
VIA
28
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$1K | – | – |
|
|
MCIA
29
Mountain Capital Investment Advisors
Westminster,
Colorado
| – | -$3K | – | – |
|